Discrepant Frozen and Permanent Diagnosis in a Lung Nodule

The error was likely partly sampling and partly interpretive, and the analysis should separate the two.

Reasoning:

• Sampling. A 4 mm fragment from the edge of a 2.4 cm spiculated nodule is a poor sample. The edge of a lepidic adenocarcinoma is often just fibrosis and organizing pneumonia, exactly what was described. The diagnostic area may not have been in the block.
• Interpretive. Well-differentiated lepidic adenocarcinoma can be subtle on frozen: alveolar architecture is preserved, and reactive pneumocyte atypia and organizing pneumonia mimic it. The pathologist may have undercalled a genuinely difficult lesion.
• Communication. The frozen report said "no definite malignancy," which is appropriately hedged, but did the surgeon understand that the sample was a small edge fragment? The frozen request should have specified the nodule center and the surgeon should have been told the sample was non-diagnostic rather than negative.
• Avoidability. Better sampling (larger, centered section) and a "deferred" or "non-diagnostic" call would likely have prevented the discrepancy. The interpretive difficulty is real but was compounded by the sample.
• Standard. Frozen section of a lung nodule should sample the most suspicious solid area, not the edge, and the pathologist should state when the sample is inadequate.

Communicate uncertainty and sample adequacy explicitly, and fix the sampling workflow.

Reasoning:

• Real-time communication. The pathologist should say: "The submitted tissue is a 4 mm edge fragment showing organizing pneumonia and fibrosis; it is not representative of the nodule center and I cannot exclude well-differentiated adenocarcinoma. This is a non-diagnostic sample." That is different from "benign."
• Surgeon decision. With a non-diagnostic frozen, the surgeon can decide to submit the nodule center for a second frozen or proceed on clinical grounds. Either way, the decision is informed.
• System fix. (1) Require the surgeon to orient and mark the nodule and submit the solid center for frozen. (2) Add a gross-room check that frozen samples are representative (size, location, radiologic correlation). (3) Build a "non-diagnostic frozen" category into the report template so it is not conflated with "negative." (4) Track frozen-permanent discrepancies in a QA log with root-cause categories (sampling vs interpretation).
• Education. Share the case at M&M with attention to lepidic patterns and the limits of frozen in well-differentiated lung adenocarcinoma.

Classify it as a frozen-permanent discrepancy with both sampling and interpretive contributions, and report it through the QA program with a defined severity.

Reasoning:

• Classification. Use a standard scheme: concordant, minor discrepancy (no clinical impact), major discrepancy (altered diagnosis or management). Here the frozen said benign and the permanent said adenocarcinoma, so it is a major discrepancy even though the surgeon had already proceeded to lobectomy.
• Clinical impact. The lobectomy was performed on clinical grounds and turned out appropriate; nodal staging was negative. The discrepancy did not change management in this case, but that is luck, not design.
• QA reporting. Log the case with the root-cause category, the corrective action (sampling protocol, non-diagnostic category), the responsible parties, and a follow-up date. Report aggregate frozen discrepancy rates to the department and the hospital quality committee.
• Confidentiality. Handle the case in peer-review protected format; do not include it in the patient's chart as a punitive note, but do document the final diagnosis clearly.
• Closure. Re-audit frozen lung cases after the protocol change to confirm the discrepancy rate falls.